Cabaletta Bio, Inc. (CABA)
NASDAQ·Healthcare·Biotechnology
$2.66
-2.56%
Mkt Cap $443.51M
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (3 analysts)
$16.33
Range $3.00 – $32.00
Implied Upside
+515.1%
Consensus $16.33 vs current $2.66
NASDAQ·Healthcare·Biotechnology
$2.66
-2.56%
Mkt Cap $443.51M
Buy
3
Hold
1
Sell
0
Price Target (3 analysts)
$16.33
Range $3.00 – $32.00
+515.1%
Consensus $16.33 vs current $2.66